Primed to feel, not to flare: Early life adversity and psychological sensitivity to interleukin-6 in a randomized trial among middle-aged female breast cancer survivors.

In 30 seconds

This randomized, placebo-controlled study examined whether early life adversity (ELA) altered inflammatory and psychological responses in 172 female breast cancer survivors. Participants received typhoid vaccine and saline injections in randomized order at separate visits, with IL-6 and psychological outcomes measured repeatedly. ELA did not moderate vaccine-induced IL-6 reactivity or the effect of injection type on psychological outcomes. However, among participants reporting at least two adverse childhood events, increases in IL-6 were associated with greater sadness (p = 0.030) and focus difficulty (p = 0.048); these associations were not significant among those reporting zero or one event.

Key findings

• Neither ELA measure moderated vaccine-induced IL-6 reactivity (ps > 0.17).
• ELA did not moderate the effect of injection type on psychological outcomes (ps > 0.25).
• With at least two adverse events, IL-6 increases were associated with greater sadness (p = 0.030) and focus difficulty (p = 0.048).
• In the higher-ELA group, the association with memory difficulty was marginal (p = 0.067), while social connection was unrelated to IL-6 (ps > 0.81).

Why it matters

The findings suggest that early adversity may shape psychological sensitivity to inflammatory changes without increasing the inflammatory response itself. This distinction may help clarify why people exposed to similar inflammatory signals can experience different mood or cognitive effects, and supports further study of ELA as a factor in vulnerability to inflammation-associated psychological symptoms.

What to keep in mind

The study involved female breast cancer survivors, so the findings may not generalize to other populations. The reported associations do not establish that IL-6 increases caused the psychological changes.